Laszlo Wagner
7PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 08, 2025
Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease.Dora B Balogh, Judit Hodrea, Adar Saeed
|Dec 09, 2023
Cardioprotective and Antifibrotic Effects of Low-Dose Renin-Angiotensin-Aldosterone System Inhibitors in Type 1 Diabetic Rat Model.Dora B Balogh, Agnes Molnar, Arianna Degi
|Jul 29, 2023
The Sigma-1 Receptor Is a Novel Target for Improving Cold Preservation in Rodent Kidney Transplants.Adam Hosszu, Akos R Toth, Tamas Lakat
|May 13, 2023
An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis.Dora Bianka Balogh, Laszlo Jozsef Wagner, Andrea Fekete
|Feb 17, 2022
SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.Judit Hodrea, Adar Saeed, Agnes Molnar
|Jun 17, 2018
The role of Sigma-1 receptor in sex-specific heat shock response in an experimental rat model of renal ischaemia/reperfusion injury.Adam Hosszu, Zsuzsanna Antal, Apor Veres-Szekely
Pageof 2
